SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ishita Drugs & Industries informs about standalone financial results

16 Aug 2016 Evaluate

Ishita Drugs & Industries has informed about Standalone Financial Results and Limited Review for the period ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Ishita Drugs & Inds. Share Price

78.75 -0.75 (-0.94%)
11-Jun-2026 12:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1802.50
Dr. Reddys Lab 1278.75
Cipla 1388.10
Zydus Lifesciences 1103.20
Lupin 2272.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: